Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

Leaders in Pharma: Danielle Portnik

In this episode of Impetus Digital's Leaders in Pharma podcast, I sit down with Danielle Portnik. She is currently the Regional Business Director for International with Ambry Genetics.

Impetus Digital

GIG Opinions - Your brand is more than a logo.

You Brand Is More Than A Logo

Jon discusses how a good logo alone does not complete the brand, especially today when that brand has to adapt and live across many channels.

The Good Ideas Group

- PMLiVE

Healthware Group appoints Yannick Valenti as digital strategy and customer engagement director

Prior to Healthware, Valenti spent three years at Ogilvy Health as digital strategy director

- PMLiVE

Lucid Group promotes Clare Reynolds to newly created role

Reynolds initially joined Lucid in 2009 as business unit director

- PMLiVE

Corin Baird joins Havas Just:: as head of digital

Baird joins the team with a varied background in digital marketing

- PMLiVE

Strategy experts: the real thing

What defines genuine strategy experts in the biomedical industry?

- PMLiVE

Versiti launches test for vaccine-related blood clot issues

Launch follows reports of very rare blood clots connected to J&J's vaccine

- PMLiVE

Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics

Drug could treat life-threatening antifungal-resistant infections

- PMLiVE

GSK’s revenue drops by 18% in Q1 as performance pressures mount

Chief executive Emma Walmsley said results ‘reflect the anticipated impacts of COVID-19’

- PMLiVE

Novartis announces delay in UK cholesterol drug study

The delay was caused by recruitment issues during the COVID-19 pandemic

- PMLiVE

ICR appoints Kristian Helin as its new chief executive

Helin will join ICR in September from the Memorial Sloan Kettering Cancer Center in the US

- PMLiVE

Lilly cuts 2021 guidance to reflect ‘lower expected revenue’ from COVID-19 antibody sales

FDA recently removed emergency authorisation for bamlanivimab monotherapy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links